19 June 2013
Keywords: ibandronate, cleared, emea, boehringer, mannheim, received, approval
Article | 08 July 1996
Boehringer Mannheim has received approval from the European Medicines Evaluation Agency for Bondronat/Bonviva (ibandronate), its bisphosphonate compound. The drug ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.